Literature DB >> 24632611

USP29 controls the stability of checkpoint adaptor Claspin by deubiquitination.

Y Martín1, E Cabrera1, H Amoedo1, S Hernández-Pérez1, R Domínguez-Kelly1, R Freire1.   

Abstract

The DNA damage checkpoint is essential for the maintenance of genome integrity after genotoxic stress, and also for cell survival in eukaryotes. Claspin has a key role in the ATR (ATM and Rad3-related)-Chk1 branch of the DNA damage checkpoint and is also required for correct DNA replication. To achieve properly these functions, Claspin is tightly regulated by ubiquitinin-dependent proteasomal degradation, which controls Claspin levels in a DNA-damage- and cell-cycle-dependent manner. Here, we identified a new regulator of Claspin, the ubiquitin-specific peptidase 29, USP29. Downregulation of USP29 destabilizes Claspin, whereas its overexpression promotes an increase in Claspin levels. USP29 interacts with Claspin and is able to deubiquitinate it both in vivo and in vitro. Most importantly, USP29 knockdown results in an impaired phosphorylation of Chk1 after DNA damage and USP29-depleted cells show a major defect in the S-phase progression. With these results, we identified USP29 as a new player in the ATR-Chk1 pathway and the control of DNA replication.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24632611     DOI: 10.1038/onc.2014.38

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

1.  USP7 controls Chk1 protein stability by direct deubiquitination.

Authors:  Ignacio Alonso-de Vega; Yusé Martín; Veronique A J Smits
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

2.  PERK inhibits DNA replication during the Unfolded Protein Response via Claspin and Chk1.

Authors:  E Cabrera; S Hernández-Pérez; S Koundrioukoff; M Debatisse; D Kim; M B Smolka; R Freire; D A Gillespie
Journal:  Oncogene       Date:  2016-07-04       Impact factor: 9.867

3.  USP37 deubiquitinates Cdt1 and contributes to regulate DNA replication.

Authors:  Santiago Hernández-Pérez; Elisa Cabrera; Hugo Amoedo; Sara Rodríguez-Acebes; Stephane Koundrioukoff; Michelle Debatisse; Juan Méndez; Raimundo Freire
Journal:  Mol Oncol       Date:  2016-06-03       Impact factor: 6.603

4.  DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer.

Authors:  S Hernández-Pérez; E Cabrera; E Salido; M Lim; L Reid; S R Lakhani; K K Khanna; J M Saunus; R Freire
Journal:  Oncogene       Date:  2017-03-13       Impact factor: 9.867

5.  Posttranscriptional control of the replication stress response via TTP-mediated Claspin mRNA stabilization.

Authors:  Tae-Hee Lee; Ji Ye Choi; Jeong-Min Park; Tae-Hong Kang
Journal:  Oncogene       Date:  2020-02-21       Impact factor: 9.867

6.  Dub3 controls DNA damage signalling by direct deubiquitination of H2AX.

Authors:  M Rocío Delgado-Díaz; Yusé Martín; Anna Berg; Raimundo Freire; Veronique A J Smits
Journal:  Mol Oncol       Date:  2014-03-18       Impact factor: 6.603

Review 7.  Deubiquitinases in cancer.

Authors:  Rongbin Wei; Xiaodong Liu; Weixin Yu; Tianshu Yang; Wenping Cai; Junjun Liu; Xiao Huang; Guo-tong Xu; Shouliang Zhao; Jianhua Yang; Shangfeng Liu
Journal:  Oncotarget       Date:  2015-05-30

8.  Ubiquitin-Specific Protease 29 Regulates Cdc25A-Mediated Tumorigenesis.

Authors:  Arun Pandian Chandrasekaran; Sang Hyeon Woo; Neha Sarodaya; Byung Ho Rhie; Apoorvi Tyagi; Soumyadip Das; Bharathi Suresh; Na Re Ko; Seung Jun Oh; Kye-Seong Kim; Suresh Ramakrishna
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

9.  Ubiquitin Specific Protease 29 Functions as an Oncogene Promoting Tumorigenesis in Colorectal Carcinoma.

Authors:  Arun Pandian Chandrasekaran; Bharathi Suresh; Neha Sarodaya; Na-Re Ko; Seung-Jun Oh; Kye-Seong Kim; Suresh Ramakrishna
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639

10.  USP29-mediated HIF1α stabilization is associated with Sorafenib resistance of hepatocellular carcinoma cells by upregulating glycolysis.

Authors:  Ruize Gao; David Buechel; Ravi K R Kalathur; Marco F Morini; Mairene Coto-Llerena; Caner Ercan; Salvatore Piscuoglio; Qian Chen; Tanja Blumer; Xueya Wang; Eva Dazert; Markus H Heim; Michael N Hall; Fengyuan Tang; Gerhard Christofori
Journal:  Oncogenesis       Date:  2021-07-16       Impact factor: 7.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.